2 not yet recruiting, 2 recruiting, 1 active not recruiting. 5 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Not yet recruiting 2, Recruiting 2, Active not recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Prostate Cancer Patients: new trials by email Literature Review of Prostate Cancer Patients trials Research Report on Prostate Cancer Patients
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Darolutamide Combined With Docetaxel and ADT as Neoadjuvant Therapy for Locally Advanced Prostate Cancer. Darolutamide, docetaxel, ADT - Prostate Cancer, Prostate | Phase 2 | Not yet recruiting | RenJi Hospital | 200 | 2026-08-01 | 2026-07-28 |
| Radiation Therapy Approaches for People With Prostate Cancer Standard of Care HDR Brachytherapy, SBRT - Prostate Cancer Patients, Non-metastatic Prostate Cancer | Phase 2 | Recruiting | Memorial Sloan Kettering Cancer Center | 126 | 2026-07-31 | 2026-08-12 |
| A Dose Optimization Study of Enzalutamide in Elderly Patients With Advanced Prostate Cancer Enzalutamide Dose Escalation, Standard of Care - Prostate Cancer Patients, Elderly Patients | Phase 2 | Not yet recruiting | Sunnybrook Health Sciences Centre | 26 | 2026-04-01 | 2026-04-06 |
| Prostate Cancer With OligometaSTatic Relapse: Combining Stereotactic Ablative Radiotherapy and Durvalumab (MEDI4736) SBRT + Durvalumab, SBRT - Node; Prostate, Bone Metastases | Phase 2 | Active not recruiting | Institut Cancerologie de l'Ouest | 96 | 2019-03-21 | 2026-03-31 |
| A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patients Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin - Prostate Cancer Patients | Phase 2 / Phase 3 | Recruiting | Shanghai Jiao Tong University School of Medicine | 300 | 2015-01-01 | 2026-01-12 |
Genital Diseases (4) · Genital Diseases, Male (4) · Genital Neoplasms, Male (4) · Male Urogenital Diseases (4) · Neoplasms (4) · Neoplasms by Site (4) · Prostatic Diseases (4) · Urogenital Diseases (4) · Urogenital Neoplasms (4)
Docetaxel (2) · Mitoxantrone (1) · Radiosurgery (1) · Standard of Care (1) · cabazitaxel (1) · darolutamide (1) · durvalumab (1) · satraplatin (1)
Institut Cancerologie de l'Ouest (1) · Memorial Sloan Kettering Cancer Center (1) · RenJi Hospital (1) · Shanghai Jiao Tong University School of Medicine (1) · Sunnybrook Health Sciences Centre (1)
Canada (1) · China (1) · France (1) · United States (1)
Daniel Gorovets, MD (1) · Daniel Khalaf, MD (1) · Yu Sun, Ph.D (1)